It is estimated that by 2022, approximately 4.82 million new instances of cancer and 3.21 million fatalities due to cancer will occur in China. Colorectal cancer (CRC) accounts for 12.3% of the total cancer incidence and 9.6% of the cancer-related deaths [1, 2]. The incidence and mortality rates of CRC,...
According to the latest global cancer statistics report, colorectal cancer (CRC) maintains a significant burden worldwide, ranking as the third most commonly diagnosed cancer with 1.92 million new cases and the second leading cause of cancer-related mortality with 0.9 million deaths [1]. This epidemiological...
Histone modifications, especially the lysine acetylation, have drawn increasing attention in cancer research area. The aim of this research is to explore the molecular mechanisms underlying the regulation of lysine acetyltransferase 2 A (KAT2A) on colorectal cancer (CRC). Clinical samples were...
Colorectal cancer (CRC) is a major contributor to global cancer incidence and mortality. Conventional treatments have limitations; hence, innovative approaches are imperative. Recent advancements in cancer research have led to the development of personalized targeted therapies and immunotherapies. Immunotherapy,...